Impact of a blood management protocol on transfusion rates and outcomes following total hip and knee arthroplasty

Annals of the Royal College of Surgeons of England

Volumn 98, Issue 6, 2016, Pages 380-386

  Frew, N ^a   Alexander, D ^a   Hood, J ^a   Acornley, A ^a  

^a Airedale NHS Trust   (United Kingdom)

Author keywords

Anaemia; Blood transfusion; Erythropoietin; Total hip replacement; Total knee replacement

Indexed keywords

ANTIANEMIC AGENT; FERRIC CARBOXYMALTOSE; FERRIC ION; FERRITIN; HEMOGLOBIN; MALTOSE; RECOMBINANT ERYTHROPOIETIN;

ANALOGS AND DERIVATIVES; ANEMIA; BLOOD; BLOOD TRANSFUSION; CLINICAL PROTOCOL; GENERAL HOSPITAL; HIP REPLACEMENT; HOSPITAL READMISSION; HUMAN; KNEE REPLACEMENT; LENGTH OF STAY; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UNITED KINGDOM;

ANEMIA; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION; CLINICAL PROTOCOLS; EPOETIN ALFA; FERRIC COMPOUNDS; FERRITINS; HEMATINICS; HEMOGLOBINS; HOSPITALS, GENERAL; HUMANS; LENGTH OF STAY; MALTOSE; PATIENT READMISSION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; UNITED KINGDOM;

EID: 84981275851     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/rcsann.2016.0139     Document Type: Article

References (28)

1. NJR StatsOnline. National Joint Registry. http://www.njrcentre.org.uk/njrcentre/ healthcareproviders/accessingthedata/statsonline/njrstatsonline/tabid/179/default. aspx (cited March 2016).
2. Wells AW, Mounter PJ, Chapman CE et al. Where does blood go? Prospective observational study of red cell transfusion in north England. BMJ 2002; 325: 803.
3. Boralessa H, Goldhill DR, Tucker K et al. National comparative audit of blood use in elective primary unilateral total hip replacement surgery in the UK. Ann R Coll Surg Engl 2009; 91: 599-605.
4. Husted H, Holm G, Jacobsen S. Predictors of length of stay and patient satisfaction after hip and knee replacement surgery. Acta Orthop 2008; 79: 168-173.
5. Pulido L, Ghanem E, Joshi A et al. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 2008; 466: 1,710-1,715.
6. Spahn DR. Anemia and patient blood management in hip and knee surgery. Anesthesiology 2010; 113: 482-495.
7. Department of Health. Better Blood Transfusion. London: DH; 2007.
8. Kotzé A, Carter LA, Scally AJ. Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. Br J Anaesth 2012; 108: 943-952.
9. Davidoff F, Batalden P, Stevens D et al. Publication guidelines for quality improvement studies in health care: evolution of the SQUIRE project. J Gen Intern Med 2008; 23: 2,125-2,130.
10. Martinez V, Monsaingeon-Lion A, Cherif K et al. Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to lower transfusion rates and hospital costs. Br J Anaesth 2007; 99: 794-800.
11. Goodnough LT, Maniatis A, Earnshaw P et al. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 2011; 106: 13-22.
12. Muñoz M, García-Erce JA, Cuenca J et al. On the role of iron therapy for reducing allogeneic blood transfusion in orthopaedic surgery. Blood Transfus 2012; 10: 8-22.
13. Theusinger OM, Kind SL, Seifert B et al. Patient blood management in orthopaedic surgery: a four-year follow-up of transfusion requirements and blood loss from 2008 to 2011 at the Balgrist University Hospital in Zurich, Switzerland. Blood Transfus 2014; 12: 195-203.
14. Shander A, Hofmann A, Ozawa S et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50: 753-765.
15. Wallis JP. Disentangling anemia and transfusion. Transfusion 2011; 51: 8-10.
16. Shander A, Knight K, Thurer R et al. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med 2004; 116(Suppl 7A): 58-69.
17. Wong CJ, Vandervoort MK, Vandervoort SL et al. A cluster-randomized controlled trial of a blood conservation algorithm in patients undergoing total hip joint arthroplasty. Transfusion 2007; 47: 832-841.
18. Musallam KM, Tamim HM, Richards T et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011; 378: 1,396-1,407.
19. Shander A, Javidroozi M, Ozawa S, Hare GM. What is really dangerous: anaemia or transfusion? Br J Anaesth 2011; 107: i41-i59.
20. Lasocki S, Krauspe R, von Heymann C et al. PREPARE: the prevalence of perioperative anaemia and need for patient blood management in elective orthopaedic surgery: a multicentre, observational study. Eur J Anaesthesiol 2015; 32: 160-167.
21. Rogers BA, Cowie A, Alcock C, Rosson JW. Identification and treatment of anaemia in patients awaiting hip replacement. Ann R Coll Surg Engl 2008; 90: 504-507.
22. National Blood Transfusion Committee. Patient Blood Management. Leeds: NHS England; 2014.
23. Rosencher N, Kerkkamp HE, Macheras G et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43: 459-469.
24. Spahn DR. Anemia and patient blood management in hip and knee surgery. Anesthesiology 2010; 113: 482-495.
25. Dr Foster. Hospital Guide 2010. London: Dr Foster; 2010.
26. Cullen C, Johnson DS, Cook G. Re-admission rates within 28 days of total hip replacement. Ann R Coll Surg Engl 2006; 88: 475-478.
27. Sukeik M, Alshryda S, Haddad FS, Mason JM. Systematic review and metaanalysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br 2011; 93: 39-46.
28. Alshryda S, Sarda P, Sukeik M et al. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br 2011; 93: 1,577-1,585.